These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34593251)

  • 21. Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients.
    Siddiqui AS; Kumar G; Majumdar T; Graviss EA; Nguyen DT; Goodarzi A; Kaleekal T
    Clin Transplant; 2018 Oct; 32(10):e13397. PubMed ID: 30192029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxygenated Hemoglobin Predicts Outcome in Patients with Chronic Lung Allograft Dysfunction.
    Kahnert K; Trudzinski FC; Berger C; Munker D; Milger K; Irlbeck M; Tomasi R; Schneider C; Michel S; Ghiani A; Herth FJF; Behr J; Jörres RA; Kneidinger N
    Respiration; 2022; 101(7):638-645. PubMed ID: 35354156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Airway Telomere Length in Lung Transplant Recipients.
    Mackintosh JA; Yerkovich ST; Tan ME; Samson L; Hopkins PM; Chambers DC
    Front Immunol; 2021; 12():658062. PubMed ID: 33936089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI-derived regional flow-volume loop parameters detect early-stage chronic lung allograft dysfunction.
    Moher Alsady T; Voskrebenzev A; Greer M; Becker L; Kaireit TF; Welte T; Wacker F; Gottlieb J; Vogel-Claussen J
    J Magn Reson Imaging; 2019 Dec; 50(6):1873-1882. PubMed ID: 31134705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early onset of azithromycin to prevent CLAD in lung transplantation: Promising results of a retrospective single centre experience.
    Cristeto Porras M; Mora Cuesta VM; Iturbe Fernández D; Tello Mena S; Alonso Lecue P; Sánchez Moreno L; Miñambres García E; Naranjo Gozalo S; Izquierdo Cuervo S; Cifrián Martínez JM
    Clin Transplant; 2023 Jan; 37(1):e14832. PubMed ID: 36217992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
    Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
    J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.
    Fisher CE; Preiksaitis CM; Lease ED; Edelman J; Kirby KA; Leisenring WM; Raghu G; Boeckh M; Limaye AP
    Clin Infect Dis; 2016 Feb; 62(3):313-319. PubMed ID: 26565010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unilateral chronic lung allograft dysfunction is a characteristic of bilateral living-donor lobar lung transplantation.
    Miyamoto E; Chen F; Aoyama A; Sato M; Yamada T; Date H
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):463-9. PubMed ID: 25468952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung transplant recipients on long-term extracorporeal photopheresis.
    Isenring B; Robinson C; Buergi U; Schuurmans MM; Kohler M; Huber LC; Benden C
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28653398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study.
    Testaert H; Bouet M; Valour F; Gigandon A; Lafon ME; Philit F; Sénéchal A; Casalegno JS; Blanchard E; Le Pavec J; Ader F
    Clin Microbiol Infect; 2021 Jun; 27(6):897-903. PubMed ID: 32827713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
    Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
    J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy of chronic lung allograft dysfunction post lung transplantation.
    Evans RA; Walter KS; Lobo LJ; Coakley R; Doligalski CT
    Clin Transplant; 2022 Aug; 36(8):e14770. PubMed ID: 35801376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
    Bacigalupo A; Lamparelli T; Barisione G; Bruzzi P; Guidi S; Alessandrino PE; di Bartolomeo P; Oneto R; Bruno B; Sacchi N; van Lint MT; Bosi A;
    Biol Blood Marrow Transplant; 2006 May; 12(5):560-5. PubMed ID: 16635791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase-resolved Functional Lung (PREFUL) MRI-derived Ventilation and Perfusion Parameters Predict Future Lung Transplant Loss.
    Vogel-Claussen J; Kaireit TF; Voskrebenzev A; Klimeš F; Glandorf J; Behrendt L; Gutberlet M; Korz C; Speth M; Welte T; Wacker F; Gottlieb J
    Radiology; 2023 May; 307(4):e221958. PubMed ID: 37070996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-acquired Respiratory Viruses Are a Risk Factor for Chronic Lung Allograft Dysfunction.
    Peghin M; Los-Arcos I; Hirsch HH; Codina G; Monforte V; Bravo C; Berastegui C; Jauregui A; Romero L; Cabral E; Ferrer R; Sacanell J; Román A; Len O; Gavaldà J
    Clin Infect Dis; 2019 Sep; 69(7):1192-1197. PubMed ID: 30561555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new classification system for chronic lung allograft dysfunction.
    Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
    J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience.
    Vazirani J; Routledge D; Snell GI; Watson D; Paraskeva M; Westall GP; Harrison SJ
    Transplant Proc; 2021; 53(1):296-302. PubMed ID: 33039145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction.
    Moniodis A; Townsend K; Rabin A; Aloum O; Stempel J; Burkett P; Camp P; Divo M; El-Chemaly S; Mallidi H; Rosas I; Fuhlbrigge A; Koo S; Goldberg HJ
    J Heart Lung Transplant; 2018 Mar; 37(3):340-348. PubMed ID: 28431983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pharmacoeconomic comparison of antithymocyte globulin and muromonab CD3 induction therapy in renal transplant recipients.
    Brennan DC; Schnitzler MA; Baty JD; Ceriotti CS; Lowell JA; Shenoy S; Howard TK; Woodward RS
    Pharmacoeconomics; 1997 Mar; 11(3):237-45. PubMed ID: 10165313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pirfenidone in chronic lung allograft dysfunction: a single cohort study.
    Bennett D; Lanzarone N; Fossi A; Perillo F; De Vita E; Luzzi L; Paladini P; Bargagli E; Sestini P; Rottoli P
    Panminerva Med; 2020 Sep; 62(3):143-149. PubMed ID: 32192319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.